<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ly HM</submitter><funding>Natural Sciences and Engineering Research Council of Canada</funding><funding>Universit? de Sherbrooke</funding><funding>Proteo</funding><pagination>3711-3726</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10946398</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>67(5)</volume><pubmed_abstract>Macrocycles have recognized therapeutic potential, but their limited cellular permeability can hinder their development as oral drugs. To better understand the structure-permeability relationship of heterocycle-containing, semipeptidic macrocycles, a library was synthesized. These compounds were created by developing two novel reactions described herein: the reduction of activated oximes by LiBH&lt;sub>4&lt;/sub> and the aqueous reductive mono-&lt;i>N&lt;/i>-alkylation of aldehydes using catalytic SmI&lt;sub>2&lt;/sub> and stoichiometric Zn. The permeability of the macrocycles was evaluated through a parallel artificial membrane permeability assay (PAMPA), and the results indicated that macrocycles with a furan incorporated into the structure have better passive permeability than those with a pyrrole moiety. Compounds bearing a 2,5-disubstituted pyrrole (&lt;i>endo&lt;/i> orientation) were shown to be implicated in intramolecular H-bonds, enhancing their permeability. This study highlighted the impact of heterocycles moieties in semipeptides, creating highly permeable macrocycles, thus showing promising avenues for passive diffusion of drugs beyond the rule-of-five chemical space.</pubmed_abstract><journal>Journal of medicinal chemistry</journal><pubmed_title>Insights on Structure-Passive Permeability Relationship in Pyrrole and Furan-Containing Macrocycles.</pubmed_title><pmcid>PMC10946398</pmcid><funding_grant_id>RGPIN-2022-04028</funding_grant_id><pubmed_authors>Desgagne M</pubmed_authors><pubmed_authors>Nguyen DT</pubmed_authors><pubmed_authors>Comeau C</pubmed_authors><pubmed_authors>Froehlich U</pubmed_authors><pubmed_authors>Marsault E</pubmed_authors><pubmed_authors>Ly HM</pubmed_authors><pubmed_authors>Boudreault PL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Insights on Structure-Passive Permeability Relationship in Pyrrole and Furan-Containing Macrocycles.</name><description>Macrocycles have recognized therapeutic potential, but their limited cellular permeability can hinder their development as oral drugs. To better understand the structure-permeability relationship of heterocycle-containing, semipeptidic macrocycles, a library was synthesized. These compounds were created by developing two novel reactions described herein: the reduction of activated oximes by LiBH&lt;sub>4&lt;/sub> and the aqueous reductive mono-&lt;i>N&lt;/i>-alkylation of aldehydes using catalytic SmI&lt;sub>2&lt;/sub> and stoichiometric Zn. The permeability of the macrocycles was evaluated through a parallel artificial membrane permeability assay (PAMPA), and the results indicated that macrocycles with a furan incorporated into the structure have better passive permeability than those with a pyrrole moiety. Compounds bearing a 2,5-disubstituted pyrrole (&lt;i>endo&lt;/i> orientation) were shown to be implicated in intramolecular H-bonds, enhancing their permeability. This study highlighted the impact of heterocycles moieties in semipeptides, creating highly permeable macrocycles, thus showing promising avenues for passive diffusion of drugs beyond the rule-of-five chemical space.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2025-04-03T23:36:28.918Z</modification><creation>2025-04-03T23:36:28.918Z</creation></dates><accession>S-EPMC10946398</accession><cross_references><pubmed>38417040</pubmed><doi>10.1021/acs.jmedchem.3c02162</doi></cross_references></HashMap>